Our data....suggests the CBD as a pharmacological tool to improve neurological dysfunctions caused by traumatic brain injury (TBI). Read full article > Continue reading

The role of the endocannabinoid system in nicotine addiction is being increasingly acknowledged. Researchers conducted a pilot, randomised double blind placebo controlled study set out to assess... Continue reading

In this study, we have investigated the effects of cannabidiol (CBD) on myocardial dysfunction, inflammation, oxidative/nitrosative stress, cell death and interrelated signaling pathways, using a... Continue reading

An animal study finds that cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may help reduce the risk of drug and alcohol relapse. The research,... Continue reading

The “classic” endocannabinoid (eCB) system includes the cannabinoid receptors CB1 and CB2, the eCB ligands anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and their metabolic enzymes. An emerging... Continue reading